Acute Kidney Disease in Hospitalized Pediatric Patients With Acute Kidney Injury in China.
acute kidney disease
acute kidney injury
epidemiology
mortality
outcomes
pediatric
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
02
2022
accepted:
12
04
2022
entrez:
9
6
2022
pubmed:
10
6
2022
medline:
10
6
2022
Statut:
epublish
Résumé
The epidemiology and outcomes of acute kidney disease (AKD) after acute kidney injury (AKI) in hospitalized children are poorly described. The aim of this study is to investigate the prevalence, predictive factors, and clinical outcomes of AKD in hospitalized children with AKI. Children (1 month-18 years) with AKI during hospitalization in the Second Xiangya Hospital from January 2015 to December 2020 were identified. AKD was defined based on the consensus report of the Acute Disease Quality Initiative 16 workgroup. The endpoints include adverse outcomes in 30 and 90 days. Multivariable logistic regression analyses were used to estimate the odds ratio of 30- and 90-day adverse outcomes associated with AKD and identify the risk factors of AKD. AKD was developed in 42.3% (419/990) of the study patients, with 186 in AKD stage 1, 107 in AKD stage 2, and 126 in AKD stage 3. Pediatric patients with AKD stages 2-3 had significantly higher rates of developing 30- and 90-day adverse outcomes than those with AKD stage 0 and 1. The adjusted odds ratio of AKD stage 2-3 was 12.18 (95% confidence interval (CI), 7.38 - 20.09) for 30-day adverse outcomes and decreased to 2.49 (95% CI, 1.26 - 4.91) for 90-day adverse outcomes. AKI stages 2 and 3, as well as glomerulonephritis, were the only predictive factors for AKD stage 2-3. AKD is frequent among hospitalized pediatric AKI patients. AKD stage 2-3 represents a high-risk subpopulation among pediatric AKI survivors and is independently associated with 30- and 90-day adverse outcomes. Awareness of the potential risks associated with AKD stage 2-3 and its risk factors may help improve outcomes through careful monitoring and timely intervention.
Identifiants
pubmed: 35676902
doi: 10.3389/fped.2022.885055
pmc: PMC9168069
doi:
Types de publication
Journal Article
Langues
eng
Pagination
885055Informations de copyright
Copyright © 2022 Deng, Yan, Zhang, Luo, Wang and Duan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Coron Artery Dis. 2019 Mar;30(2):87-92
pubmed: 30422833
Adv Chronic Kidney Dis. 2017 Nov;24(6):380-387
pubmed: 29229169
Pediatr Transplant. 2022 Sep;26(6):e14172
pubmed: 34668615
Crit Care Med. 2016 Dec;44(12):2241-2250
pubmed: 27513354
Nat Rev Nephrol. 2017 Apr;13(4):241-257
pubmed: 28239173
JAMA Netw Open. 2019 Apr 5;2(4):e191795
pubmed: 30951162
Pharmacol Ther. 2016 Jul;163:58-73
pubmed: 27108948
Am J Respir Crit Care Med. 2017 Mar 15;195(6):784-791
pubmed: 27635668
Ann Surg. 2016 Jun;263(6):1219-1227
pubmed: 26181482
Pediatr Nephrol. 2022 Mar;37(3):659-665
pubmed: 34386849
J Am Soc Nephrol. 2016 Mar;27(3):687-97
pubmed: 26519085
PeerJ. 2021 May 24;9:e11400
pubmed: 34113486
N Engl J Med. 2017 Jan 5;376(1):11-20
pubmed: 27959707
Clin J Am Soc Nephrol. 2014 Mar;9(3):457-61
pubmed: 24311710
Am J Kidney Dis. 2016 May;67(5):742-52
pubmed: 26690912
J Am Soc Nephrol. 2021 Aug;32(8):2005-2019
pubmed: 34039667
Kidney Int. 2015 Mar;87(3):632-9
pubmed: 25252027
Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1791-1800
pubmed: 30287424
N Engl J Med. 2018 Mar 1;378(9):829-839
pubmed: 29485925
Clin J Am Soc Nephrol. 2012 May;7(5):844-50
pubmed: 22442182